Search for Ranbaxy Laboratories Ltd and
    1. April 7, 2014

      Daiichi / Ranbaxy: race for the exit

      When Daiichi Sankyo bought its majority stake in Ranbaxy, investors cheered it with a 5 per cent share price rally. They...

    2. April 7, 2014

      India’s Sun Pharma offers $3.2bn for ailing Ranbaxy

      Sun Pharmaceutical Industries has agreed to pay $3.2bn for the equity in Ranbaxy, the Indian generic drugmaker that has...

    1. February 2, 2014

      Ranbaxy in need of further treatment

      Arun Sawhney wanted to be clear. “Ranbaxy is a different company today”, the chief executive of the Indian drugs group said...

    2. January 24, 2014

      Ranbaxy shares sink on US FDA product ban

      Shares in Ranbaxy, the troubled Indian pharmaceutical company, plunged 20 per cent after the US banned imports from a fourth...

    3. September 16, 2013

      Ranbaxy Laboratories: pills & spills

      Something is very wrong at Ranbaxy Laboratories. The Indian generic drugmaker’s shares fell 30 per cent on Monday after the...

    4. September 4, 2013

      India approves $1.6bn acquisition of Agila Specialties by Mylan

      India’s government has given the go-ahead for US-based pharmaceutical company Mylan’s long-stalled $1.6bn acquisition of...

    5. June 19, 2013

      Lundbeck fined €94m for ‘pay for delay’ deals to rivals

      European regulators have fined Lundbeck, the Danish pharmaceutical company, €94m for paying rivals to delay cut-price...

    6. beyondbrics

      May 23, 2013

      India's Ranbaxy: another can of worms

      Last week Ranbaxy Laboratories, India’s biggest pharmaceuticals company, must have thought it had at last settled an...

    7. beyondbrics

      May 14, 2013

      Ranbaxy pleads guilty and settles US felony but outlook remains unclear

      The US subsidiary of Ranbaxy Laboratories, India’s biggest pharmaceuticals group, has pleaded guilty to felony charges...

    8. April 3, 2013

      India benefits from Japan Inc shift

      As Indian finance minister Palaniappan Chidambaram wraps up an investment promotion trip to Tokyo on Wednesday, he has...

    9. beyondbrics

      February 27, 2013

      Ranbaxy: losses, again

      Shares in Indian generic drugs group Ranbaxy Laboratories dropped 4.2 per cent on Wednesday to Rs399.20, having lost 4 per...

    10. beyondbrics

      April 26, 2012

      Ranbaxy creates India's first new drug

      With the Wednesday launch of Synriam, an anti-malarial, Ranbaxy Laboratories became the first Indian pharmaceutical company...

    11. January 18, 2012

      Takeda to axe tenth of workforce in revamp

      Japanese drug company Takeda is to close sites and cut 2,800 jobs in Europe and North America – almost a tenth of its total...

    12. December 21, 2011

      Ranbaxy makes $500m provision on FDA deal

      Ranbaxy of India has set aside $500m to cover liabilities to settle potential claims in an extended legal dispute in the US,...

    13. December 21, 2011

      Daiichi Sankyo - bad medicine

      The directors of Daiichi Sankyo, Japan’s fourth-largest drugmaker, are not particularly wealthy men. Average total...

    14. December 5, 2011

      Pfizer tactics to combat generic drugmakers

      Controversial tactics that Pfizer is using to protect revenues of Lipitor, its top-selling cholesterol drug that lost patent...

    15. beyondbrics

      December 1, 2011

      Ranbaxy's relief after FDA approval

      Shares of India’s biggest pharmaceutical company, Ranbaxy Laboratories, opened up 10.4 per cent on Thursday, following news...

    16. beyondbrics

      November 30, 2011

      Ranbaxy's high blood pressure day

      Wednesday should have been a great day for India’s largest pharmaceutical company, Ranbaxy Laboratories. After all, it is...

    17. November 29, 2011

      Pfizer bids farewell to cholesterol drug rights

      Pfizer on Wednesday bids farewell to its exclusive rights to distribute Lipitor, the best selling drug in the pharmaceutical...

    18. beyondbrics

      October 10, 2011

      India's Religare: navigating the storms

      embed1 Religare Enterprises, the Indian financial services group, sees the global market turmoil as a potential opportunity...

    19. August 8, 2011

      Schincariol bid raises questions for Japan Inc

      Schincariol is not Japan Inc’s first brush with tough acquisitions. Three years before Kirin, the Japanese beer group,...

    20. June 27, 2011

      Japan: Drug companies seek growth fillip abroad

      Yasuchika Hasegawa, chief executive of Takeda, does not mince his words when he talks about domestic acquisitions. “We are...

    21. March 17, 2011

      Asia manufacturers yet to see quake impact

      Companies across Asia said they had so far seen little impact on the region’s complex manufacturing supply chain from the...

    22. March 2, 2011

      Daiichi Sankyo to buy US drugmaker

      Daiichi Sankyo has agreed to acquire a privately held US drugmaker for just under $1bn, the latest in a string of purchases...

    23. January 26, 2011

      Pharmaceuticals: Rich pickings at home and abroad

      International pharmaceutical companies once looked with frustration at Indian drug makers, which were notorious for churning...

    24. January 24, 2011

      The professional family business

      Wipro chairman Azim Premji The great family business is a powerful institution in India where about 95 per cent of all...

    25. January 5, 2011

      Innovation: Replicators no more

      The Pulpy fruit-based drink has been developed by Coca-Cola Pulpy may be an unfamiliar brand in London, New York or Tokyo....

    26. January 3, 2011

      India eyes drug industry ownership curbs

      An outcry over foreign takeovers of Indian pharmaceuticals companies has prompted the government to consider imposing limits...

    27. November 29, 2010

      Indian stocks recover after corruption probes

      Indian stocks halted their longest slide for six months as investors judged last week’s sell-off in the wake of the...

    28. November 19, 2010

      Scrutiny of Big Pharma set to intensify

      It may take many years to bring innovative medicines to market, but when things go wrong after launch with their production,...

    29. November 14, 2010

      Religare eyes emerging markets deals

      Religare Capital Markets, backed by the Indian billionaire Singh family, is planning acquisitions in four developing...

    30. August 23, 2010

      Challenges ahead for Sanofi chief

      Sanofi-Aventis has been cited as a possible buyer of Genzyme because of its long culture of dealmaking The French may...

    31. August 20, 2010

      Chinese pharma finds partner in India

      With a fast-growing and lucrative domestic market, most Chinese pharmaceutical companies have spurned the costs and...

    32. August 12, 2010

      Ranbaxy chief in unexpected departure

      India’s largest generics drugs producer, Ranbaxy Laboratories, on Thursday lost its second chief executive in little more...

    33. August 6, 2010

      Indian groups failing to plan for successor

      In a country where corporate leaders and politicians enjoy extraordinary professional longevity, lack of succession planning...

    34. July 26, 2010

      Khazanah trumps Fortis in Parkway battle

      Malaysia’s sovereign wealth fund Khazanah Nasional is set to take control of Parkway Holdings, Asia’s biggest listed...

    35. July 14, 2010

      Aids prognosis uncertain in New Delhi

      In 2006 Prashant Buradkar was bankrupt and close to death. The driver from the small Indian industrial town of Chandrapur...

    36. May 31, 2010

      Drugmakers realise FDA has learnt to bite

      If Johnson & Johnson underestimated long-simmering concerns about the manufacturing quality of leading drug brands including...

    37. May 27, 2010

      Sanofi receives interest in animal health assets

      Sanofi-Aventis, the French drugmaker, said on Thursday that it had received “significant interest” in its animal health...

    38. May 27, 2010

      Piramal to launch own drug 'by 2012'

      India's Piramal group plans to use part of the $3.7bn it received from the sale of its generic drugs unit to Abbott...

    Search for Ranbaxy Laboratories Ltd and